SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.39
-$0.12 (-0.37%)
At close: Oct 30, 2026, 3:59 PM ET
$32.24
-$0.15 (-0.46%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 96.36M |
Short-Term Investments | 11.08M |
Long-Term Investments | n/a |
Other Long-Term Assets | 3.21M |
Receivables | 431K |
Inventory | n/a |
Other Current Assets | n/a |
Total Current Assets | 108.77M |
Property-Plant & Equipment | 3.89M |
Goodwill & Intangibles | n/a |
Total Long-Term Assets | 7.1M |
Total Assets | 115.87M |
Account Payables | 2.7M |
Deferred Revenue | n/a |
Short-Term Debt | n/a |
Other Current Liabilities | 5.89M |
Total Current Liabilities | 8.58M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 204.54M |
Total Long-Term Liabilities | 206.12M |
Total Liabilities | 214.7M |
Total Debt | 1.58M |
Book Value | -98.84M |
Book Value Per Share | -3.10 |
Common Stock | n/a |
Retained Earnings | -104.73M |
Comprehensive Income | n/a |
Shareholders Equity | -98.84M |
Total Investments | 11.08M |
Add to Watchlist
Select watchlists to add or remove SGP